申请人:Allergan, Inc.
公开号:US05376676A1
公开(公告)日:1994-12-27
4-(C.sub.10 -C.sub.20)alkyl-2(5H)-furanone compounds are selective calcium channel inhibitors and useful for treatment of diseases such as hypertension, angina, cardiac arrythmia, pulmonary hypertension, aortic insufficiency, Raynand's disease, migraine headaches, deficiency of platelet function, atherosclerosis, ischemia, reprofusion injury, bronchial asthma, esophageal spasm, dysmenorhea, allergic contact dermatitis, acute inflammatory response, glaucoma and as potentiators of chemotherapeutic agents in the treatment of tumors.
4-(C.sub.10 -C.sub.20)烷基-2(5H)-呋喃酮类化合物是选择性钙通道抑制剂,可用于治疗高血压、心绞痛、心律失常、肺动脉高压、主动脉瓣不全、雷诺病、偏头痛、血小板功能缺陷、动脉粥样硬化、缺血、再灌注损伤、支气管哮喘、食管痉挛、痛经、过敏性接触性皮炎、急性炎症反应、青光眼,并在肿瘤治疗中作为化疗药物的增效剂。